CymitQuimica logo
Cystéine protéase

Cystéine protéase

Les inhibiteurs de protéases à cystéine sont des composés qui ciblent et inhibent les protéases à cystéine, une classe d'enzymes qui décomposent les protéines en clivant les liaisons peptidiques dans lesquelles un résidu de cystéine agit comme nucléophile. Ces enzymes sont impliquées dans divers processus physiologiques, tels que l'apoptose, la réponse immunitaire et le renouvellement des protéines. Les inhibiteurs de protéases à cystéine sont essentiels pour l'étude de maladies telles que le cancer, les troubles neurodégénératifs et les infections parasitaires. Chez CymitQuimica, nous fournissons des inhibiteurs de protéases à cystéine pour soutenir vos recherches en protéolyse, régulation cellulaire et découverte de médicaments.

144 produits trouvés pour "Cystéine protéase".

produits par page.
  • SmCB1-IN-1


    SmCB1-IN-1 (Compound 2h) is an inhibitor of the Schistosoma mansoni cathepsin B1 (SmCB1) with a Ki of 0.05 μM. It demonstrates selectivity towards non-target human proteases, showing inhibition rates of 29% for CatB and 37% for CatL at 20 μM. At 1 μM, SmCB1-IN-1 inhibits 68% of Schistosoma mansoni.
    Formule :C26H25NO6S
    Couleur et forme :Solid
    Masse moléculaire :479.14026
  • Cathepsin D and E FRET Substrate

    CAS :
    Mca-GKPILFFRL-Dpa-r-amide, FRET substrate for cathepsin D and E. Also cleaved by napsin A.
    Formule :C85H122N22O19
    Couleur et forme :Solid
    Masse moléculaire :1756.046
  • Cathepsin C-IN-6


    Cathepsin C-IN-6 (compound 2), an E-64c-hydrazideas-derived inhibitor of cathepsin C, possesses anti-inflammatory properties and impedes neutrophil elastase
    Formule :C24H35N5O4·xC2HF3O2
    Couleur et forme :Solid
  • Leupeptin

    CAS :
    Leupeptin, from actinomycetes, inhibits various proteases (e.g., trypsin, plasmin, kallikrein, papain, cathepsin B) but not α-chymotrypsin/thrombin.
    Formule :C20H38N6O4
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :426.562
  • FGA146


    FGA146 is a selective inhibitor of Mpro and human Cathepsin L, with Ki values of 2.19 μM for Mal-Mpro, 0.96 μM for pET21-Mpro, and 0.87 μM for Cathepsin L. It exhibits antiviral activity against SARS-CoV-2.
    Formule :C24H31N5O6
    Masse moléculaire :485.22743
  • N-Ethylmaleimide-D5

    CAS :
    N-Ethylmaleimide-D5 is the deuterated form of N-Ethylmaleimide (T3088) (NEM). N-Ethylmaleimide (T3088) acts as an alkylating agent for free thiol groups and serves as an inhibitor of cysteine proteinases. It specifically inhibits phosphate transport within mitochondria. Additionally, N-Ethylmaleimide (T3088) functions as an inhibitor of deubiquitinating enzymes (deubiquitinatingenzyme).
    Formule :C6H7NO2
    Masse moléculaire :130.16
  • 6,6′-Dihydroxythiobinupharidine

    CAS :
    6,6′-Dihydroxythiobinupharidine, a cysteine proteases inhibitor, amplifies DNA cleavage facilitated by human topoisomerase IIα and IIβ by approximately 8-fold
    Formule :C30H42N2O4S
    Couleur et forme :Solid
    Masse moléculaire :526.73
  • Acetyl-Calpastatin (184-210)(human) acetate


    Acetyl-Calpastatin acetate inhibits µ-calpain (Ki=0.2nM) and cathepsin L (Ki=6μM) selectively and reversibly.
    Formule :C144H234N36O46S
    Degré de pureté :98.16% - 99.05%
    Couleur et forme :Solid
    Masse moléculaire :3237.68
  • Cathepsin L-IN-3 TFA


    CathepsinL-IN-3 (Compound cat L inh. 7) TFA is a selective, non-covalent inhibitor of cathepsin L, with a Ki value of 4.3 nM.
  • RO5461111

    CAS :
    RO5461111: Oral Cathepsin S inhibitor, IC50 of 0.4 nM (human) & 0.5 nM (mouse), reduces T/B cell activation, treats lung inflammation & lupus nephritis.
    Formule :C27H24F6N4O4S
    Couleur et forme :Solid
    Masse moléculaire :614.56
  • Cathepsin D and E FRET Substrate acetate


    Fluorogenic substrate for cathepsins D & E, not B/H/L; useful in their mechanistic studies.
    Formule :C86H124N22O21
    Degré de pureté :96.47%
    Couleur et forme :Yellow Solid
    Masse moléculaire :1802.04
  • N-CBZ-Phe-Arg-AMC

    CAS :
    Z-FR-AMC substrate for serine proteases; cathepsins, kallikrein, plasmin. Substrate: 330/390 nm; Product: 342/441 nm.
    Formule :C33H37ClN6O6
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :649.136
  • FGA145


    FGA145 is a dual inhibitor of Mpro and human Cathepsin L, with Ki values of 3.71 μM for Mal-Mpro, 9.82 μM for pET21-Mpro, and 53 nM for Cathepsin L. Additionally, FGA145 exhibits multi-target antiviral activity.
    Formule :C23H30N4O5
    Masse moléculaire :442.22162
  • SQ 32602

    CAS :
    SQ 32602 is a cathepsin E inhibitor.
    Formule :C32H52N3O7P
    Couleur et forme :Solid
    Masse moléculaire :621.74
  • Z-Phe-Tyr(tBu)-diazomethylketone

    CAS :
    Irreversible cathepsin L inhibitor which is ca 10'000 times more effective in inactivating cathepsin L than cathepsin S.
    Formule :C31H34N4O5
    Couleur et forme :Solid
    Masse moléculaire :542.636
  • Z-L(D-Val)G-CHN2


    Z-L(D-Val)G-CHN2, an isoform of Z-LVG-CHN2, serves as a cell-permeable and irreversible inhibitor of cysteine proteinase.
    Formule :C22H31N5O5
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :445.51
  • Relacatib

    CAS :
    Relacatib (SB-462795) is a potent cathepsins K, L, V inhibitor with high affinity (Ki: 41-68 pM) and reduces bone resorption effectively.
    Formule :C27H32N4O6S
    Couleur et forme :Solid
    Masse moléculaire :540.631
  • Z-FG-NHO-Bz

    CAS :
    Z-FG-NHO-Bz is a selective inhibitor of cathepsin [1].
    Formule :C26H25N3O6
    Couleur et forme :Solid
    Masse moléculaire :475.49
  • SARS-CoV-2-IN-77


    SARS-CoV-2-IN-77 (compound 11e) is an inhibitor of cathepsin L and cathepsin S, with Ki values of 111 nM and 103 nM, respectively. It effectively inhibits SARS-CoV-2 in Calu-3 cells with an EC50 value of 38.4 nM and does not exhibit cytotoxicity.
    Formule :C23H25Cl2N3O3
    Masse moléculaire :461.1273
  • MPI8 TFA


    MPI8 (TG0205221) TFA is an inhibitor specifically designed for SARS-CoV-2 main protease (MPro), exhibiting significant antiviral activity. Its antiviral effects are achieved through the dual and selective inhibition of both SARS-CoV-2 MPro and the host cell's cysteine protease L (cathepsin L). MPI8 TFA is applicable for clinical research related to COVID-19.